Eleos raises $60 million for AI scribe for behavioral health providers
Eleos Health, which makes software that generates clinical notes from the audio of behavioral health appointments, has raised $60 million.
Related Articles
Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs
Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass compounding” of GLP-1…
A new practical way to implement predictive analytics in healthcare
Fostering a culture of transparency, accuracy, and respect for patient data may be key to fully realise AI’s potential in healthcare, says a healthcare data…
Health care costs: one of the biggest obstacles to reshoring American industry
If the U.S. is serious about reshoring manufacturing jobs, it needs to address the factors that lead to offshoring those jobs in the first place,…
FDA chief’s goals of ‘radical transparency’ threatened by agency cuts
FDA chief wants more transparency and fewer conflicts of interest. Staff warn cuts may do the opposite.
The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir
Gilead’s twice-a-year HIV prevention drug lenacapavir is 30 years in the making. Here’s the story behind it.
Healthcare push: Amazon India launches at-home diagnostics in 6 cities, adds to pharmacy and clinic services – Times of India
India Business News: Amazon India has introduced at-home diagnostics services in six major cities, expanding its healthcare offerings under Amazon Medical. In collaboratio
Ex-Ola CMO’s startup to develop small hospitals across India
Varun Dubey, the previous Chief Marketing Officer (CMO) at Ola, has started a new healthcare startup called Superhealth Hospitals Pvt Ltd. The Bengaluru-based company plans…
Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official
The ouster of the FDA’s chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a drug review, STAT…
Why MAHA wants whole milk back on the table
In the nutrition world, the question of how whole milk compares with lower-fat options is the subject of debate. In MAHA world, it’s time to…
Novo Nordisk’s amylin obesity drug keeps performing like Zepbound
Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new late-stage results for CagriSema.